Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Nishiwaki, Satoshi ^a,b   Nakayama, Takayuki ^c   Murata, Makoto ^a   Nishida, Tetsuya ^a   Terakura, Seitaro ^a   Saito, Shigeki ^a   Kato, Tomonori ^a   Mizuno, Hiroki ^a   Imahashi, Nobuhiko ^a,b   Seto, Aika ^b   Ozawa, Yukiyasu ^b   Miyamura, Koichi ^b   Ito, Masafumi ^b   Takeshita, Kyosuke ^a   Kato, Hidefumi ^c   Toyokuni, Shinya ^a   Nagao, Keisuke ^d   Ueda, Ryuzo ^c   Naoe, Tomoki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL FUNCTION; CELL INFILTRATION; CELL MIGRATION; CELL VIABILITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GRAFT VERSUS HOST REACTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; TREATMENT DURATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL LINE; DISEASE MODEL; DRUG EFFECTS; GRAFT VS HOST DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPHOCYTE;

ANIMALS; CELL LINE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 84900551607     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096252     Document Type: Article

References (35)

1. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686. (Pubitemid 39457982)
2. Stoy N (2001) Macrophage biology and pathobiology in the evolution of immune responses: a functional analysis. Pathobiology 69: 179-211.
3. Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, et al. (2011) An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 121: 985-997.
4. Van Lint MT, Milone G, Leotta S, Uderzo C, Scime R, et al. (2006) Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin. Blood 107: 4177-4181. (Pubitemid 43726830)
5. Nishiwaki S, Terakura S, Ito M, Goto T, Seto A, et al. (2009) Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease. Blood 114: 3113-3116.
6. Schaer DJ, Alayash AI, Buehler PW (2007) Gating the radical hemoglobin to macrophages: the anti-inflammatory role of CD163, a scavenger receptor. Antioxid Redox Signal 9: 991-999. (Pubitemid 46919600)
7. Muller M, Renkawitz R (1991) The glucocorticoid receptor. Biochim Biophys Acta 1088: 171-182.
8. Pak CC, Fidler IJ (1991) Liposomal delivery of biological response modifiers to macrophages. Biotherapy 3: 55-64.
9. Xia W, Hilgenbrink AR, Matteson EL, Lockwood MB, Cheng JX, et al. (2009) A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 113: 438-446.
10. Nagao K, Ginhoux F, Leitner WW, Motegi S, Bennett CL, et al. (2009) Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci U S A 106: 3312-3317.
11. Ringden O, Hermans J, Labopin M, Apperley J, Gorin NC, et al. (1996) The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT). Leuk Lymphoma 24: 71-79.
12. Gratwohl A, Hermans J, Apperley J, Arcese W, Bacigalupo A, et al. (1995) Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation. Blood 86: 813-818.
13. Baron F, Labopin M, Niederwieser D, Vigouroux S, Cornelissen JJ, et al. (2012) Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation. Leukemia 26: 2462-2468.
14. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J, Jr., et al. (1996) An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 88: 3230-3239. (Pubitemid 26357409)
15. Kaplan DH, Anderson BE, McNiff JM, Jain D, Shlomchik MJ, et al. (2004) Target antigens determine graft-versus-host disease phenotype. J Immunol 173: 5467-5475. (Pubitemid 39392131)
16. Hill GR, Cooke KR, Teshima T, Crawford JM, Keith JC, Jr., et al. (1998) Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. J Clin Invest 102: 115-123. (Pubitemid 28323837)
17. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
18. Saito S, Nakayama T, Hashimoto N, Miyata Y, Egashira K, et al. (2011) Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CCL2 greatly attenuate bleomycin-induced lung damage. Am J Pathol 179: 1088-1094.
19. Nakayama T, Mutsuga N, Yao L, Tosato G (2006) Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells. J Leukoc Biol 79: 95-104. (Pubitemid 43054254)
20. Kondo S, Toyokuni S, Tsuruyama T, Ozeki M, Tachibana T, et al. (2002) Peroxynitrite-mediated stress is associated with proliferation of human metastatic colorectal carcinoma in the liver. Cancer Lett 179: 87-93. (Pubitemid 34195657)
21. Toyokuni S, Kawaguchi W, Akatsuka S, Hiroyasu M, Hiai H (2003) Intermittent microwave irradiation facilitates antigen-antibody reaction in Western blot analysis. Pathol Int 53: 259-261. (Pubitemid 36628236)
22. Leong AS, Milios J (1986) Rapid immunoperoxidase staining of lymphocyte antigens using microwave irradiation. J Pathol 148: 183-187. (Pubitemid 16111187)
23. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, et al. (2011) CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475: 222-225.
24. Thiele J, Kvasnicka HM, Beelen DW, Wenzel P, Koepke ML, et al. (2000) Macrophages and their subpopulations following allogenic bone marrow transplantation for chronic myeloid leukaemia. Virchows Arch 437: 160-166. (Pubitemid 30623575)
25. Blirando K, Milliat F, Martelly I, Sabourin JC, Benderitter M, et al. (2011) Mast cells are an essential component of human radiation proctitis and contribute to experimental colorectal damage in mice. Am J Pathol 178: 640-651.
26. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555. (Pubitemid 35223554)
27. Shin S, Moon S, Park Y, Kwon J, Lee S, et al. (2009) Role of Cordycepin and Adenosine on the Phenotypic Switch of Macrophages via Induced Antiinflammatory Cytokines. Immune Netw 9: 255-264.
28. Fuentes-Duculan J, Suarez-Farinas M, Zaba LC, Nograles KE, Pierson KC, et al. (2010) A subpopulation of CD163-positive macrophages is classically activated in psoriasis. J Invest Dermatol 130: 2412-2422.
29. Pullarkat V, Blanchard S, Tegtmeier B, Dagis A, Patane K, et al. (2008) Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 42: 799-805.
30. Hashimoto D, Chow A, Greter M, Saenger Y, Kwan WH, et al. (2011) Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation. J Exp Med 208: 1069-1082.
31. Everse LA, Anderson LD, Jr., van Rooijen N, Mullen CA (2001) Bone marrow transplant conditioning intensified with liposomal clodronate to eliminate residual host antigen presenting cells fails to ameliorate GVHD and increases PERI-BMT mortality. Transplantation 71: 611-618. (Pubitemid 32268061)
32. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, et al. (1999) Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285: 412-415. (Pubitemid 29343964)
33. Merad M, Hoffmann P, Ranheim E, Slaymaker S, Manz MG, et al. (2004) Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med 10: 510-517. (Pubitemid 38667910)
34. Wilson J, Cullup H, Lourie R, Sheng Y, Palkova A, et al. (2009) Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease. J Exp Med 206: 387-398.
35. Li N, Chen Y, He W, Yi T, Zhao D, et al. (2009) Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI. Blood 113: 953-962.